Adial Pharmaceuticals, Inc.
ADIL
$0.3721
$0.00010.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.45M | -8.95M | -13.20M | -13.05M | -12.24M |
| Total Depreciation and Amortization | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.06M | 1.26M | 5.89M | 6.00M | 6.09M |
| Change in Net Operating Assets | 910.80K | 809.70K | 386.20K | 356.30K | -233.80K |
| Cash from Operations | -6.48M | -6.88M | -6.92M | -6.69M | -6.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 350.00K | 700.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 150.00K | -- | -- | -- |
| Other Investing Activities | 150.00K | -- | -- | -- | -- |
| Cash from Investing | 150.00K | 150.00K | -- | 350.00K | 700.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.96M | 4.07M | 7.85M | 7.85M | 4.38M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -1.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 3.38M | 3.38M |
| Cash from Financing | 8.96M | 4.07M | 7.85M | 11.23M | 7.76M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.63M | -2.66M | 923.40K | 4.89M | 2.07M |